{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T23:57:33Z","timestamp":1694995053394},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T00:00:00Z","timestamp":1344470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s13730-012-0028-z","type":"journal-article","created":{"date-parts":[[2012,8,7]],"date-time":"2012-08-07T23:00:01Z","timestamp":1344380401000},"page":"1-5","source":"Crossref","is-referenced-by-count":1,"title":["A distinct lymphocyte distribution in relapse after rituximab for steroid-dependent nephrotic syndrome"],"prefix":"10.1007","volume":"2","author":[{"given":"Masaki","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadafumi","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhide","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Yachie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,9]]},"reference":[{"key":"28_CR1","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0140-6736(70)91905-7","volume":"760","author":"J Churg","year":"1970","unstructured":"Churg J, Habib R, White RHR. Pathology of nephritic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet. 1970;760:1299\u2013302.","journal-title":"Lancet"},{"key":"28_CR2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MOP.0b013e3282f4307a","volume":"20","author":"EM Hodson","year":"2008","unstructured":"Hodson EM, Alexander SI. Evaluation and management of steroid-sensitive nephrotic syndrome. Curr Opin Pediatr. 2008;20:145\u201350.","journal-title":"Curr Opin Pediatr"},{"key":"28_CR3","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1007\/s00467-005-1964-z","volume":"20","author":"A Moudgil","year":"2005","unstructured":"Moudgil A, Bagga A, Jordan SC. Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions. Pediatr Nephrol. 2005;20:1376\u201381.","journal-title":"Pediatr Nephrol"},{"key":"28_CR4","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s00467-011-1886-x","volume":"26","author":"S Ito","year":"2011","unstructured":"Ito S, Kamei K, Ogura M, Sato M, Fujimaru T, Ishikawa T, Udagawa T, Iijima K. Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome. Pediatr Nephrol. 2011;26:1823\u20138.","journal-title":"Pediatr Nephrol"},{"key":"28_CR5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00467-009-1377-5","volume":"25","author":"S Fujinaga","year":"2010","unstructured":"Fujinaga S, Hirano D, Nishizaki N, Kamei K, Ito S, Ohtomo Y, Shimizu T, Kaneko K. Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine. Pediatr Nephrol. 2010;25:539\u201344.","journal-title":"Pediatr Nephrol"},{"key":"28_CR6","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00467-008-0814-1","volume":"23","author":"V Guigonis","year":"2008","unstructured":"Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, Groothoff J, Llanas B, Niaudet P, Nivet H, Raynaud N, Taque S, Ronco P, Bouissou F. Rituximab treatment for severe steroid-or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol. 2008;23:1269\u201379.","journal-title":"Pediatr Nephrol"},{"key":"28_CR7","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/ndt\/gfr405","volume":"27","author":"AL Sellier-Leclerc","year":"2012","unstructured":"Sellier-Leclerc AL, Baudouin V, Kwon T, Macher MA, Gu\u00e9rin V, Lapillonne H, Desch\u00eanes G, Ulinski T. Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood\u2014follow-up after CD19 recovery. Nephrol Dial Transplant. 2012;27:1083\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"28_CR8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10157-011-0465-6","volume":"15","author":"T Takei","year":"2011","unstructured":"Takei T, Nitta K. Rituximab and minimal change nephrotic syndrome: therapeutic option. Clin Exp Nephrol. 2011;15:641\u20137.","journal-title":"Clin Exp Nephrol"},{"key":"28_CR9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","volume":"2","author":"RJ Shalhoub","year":"1974","unstructured":"Shalhoub RJ. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet. 1974;2:556\u201360.","journal-title":"Lancet"},{"key":"28_CR10","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1053\/ajkd.2002.32769","volume":"39","author":"G Lama","year":"2002","unstructured":"Lama G, Luongo I, Tirino G, Borriello A, Carangio C, Salsano ME. T-lymphocyte populations and cytokines in childhood nephrotic syndrome. Am J Kidney Dis. 2002;39:958\u201365.","journal-title":"Am J Kidney Dis"},{"key":"28_CR11","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1046\/j.1523-1755.2000.00870.x","volume":"57","author":"C Frank","year":"2000","unstructured":"Frank C, Herrmann M, Fernandez S, Dirnecker D, B\u00f6swald M, Kolowos W, Ruder H, Haas JP. Dominant T cells in idiopathic nephrotic syndrome of childhood. Kidney Int. 2000;57:510\u20137.","journal-title":"Kidney Int"},{"key":"28_CR12","first-page":"1348","volume":"10","author":"TJ Neuhaus","year":"1995","unstructured":"Neuhaus TJ, Shah V, Callard RE, Barratt TM. T-lymphocyte activation in steroid-sensitive nephrotic syndrome in childhood. Nephrol Dial Transplant. 1995;10:1348\u201352.","journal-title":"Nephrol Dial Transplant"},{"key":"28_CR13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000045049","volume":"79","author":"K Yan","year":"1998","unstructured":"Yan K, Nakahara K, Awa S, Nishibori Y, Nakajima N, Kataoka S, Maeda M, Watanabe T, Matsushima S, Watanabe N. The increase of memory T cell subsets in children with idiopathic nephrotic syndrome. Nephron. 1998;79:274\u20138.","journal-title":"Nephron"},{"key":"28_CR14","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/ar1954","volume":"8","author":"M Vigna-Perez","year":"2006","unstructured":"Vigna-Perez M, Hernandez-Castro B, Paredes-Saharopulos O, Portales-P\u00e9rez D, Baranda L, Abud-Mendoza C, Gonz\u00e1lez-Amaro R. Clinical and immunological effects of rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study. Arthr Res Ther. 2006;8:R83.","journal-title":"Arthr Res Ther"},{"key":"28_CR15","first-page":"e53","volume":"23","author":"M Shimizu","year":"2010","unstructured":"Shimizu M, Kitagawa K, Nishio S, Yokoyama T, Furuichi K, Ohta K, Wada T, Yachie A. Successful treatment of recurrent focal segmental glomerulosclerosis after renal transplantation by lymphocytapheresis and rituximab. Transpl Int. 2010;23:e53\u20135.","journal-title":"Transpl Int"},{"key":"28_CR16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1046\/j.1328-8067.2001.01533.x","volume":"44","author":"M Honda","year":"2002","unstructured":"Honda M. Nephrotic syndrome and mizoribine in children. Pediatr Int. 2002;44:210\u20136.","journal-title":"Pediatr Int"},{"key":"28_CR17","doi-asserted-by":"crossref","unstructured":"Fujinaga S, Endo A, Watanabe T, Hirano D, Ohtomo Y, Shimizu T, Kaneko K. Maintenance therapy with single-daily, high-dose mizoribine after cyclophosphamide therapy for prepubertal boys with severe steroid-dependent nephrotic syndrome. Clin Nephrol. 2012 [Epub ahead of print].","DOI":"10.5414\/CN107500"},{"key":"28_CR18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00467-001-0817-7","volume":"17","author":"MJ Kemper","year":"2002","unstructured":"Kemper MJ, Altrogge H, Ganschow R, M\u00fcller-Wiefel DE. Serum levels of immunoglobulins and IgG subclasses in steroid sensitive nephrotic syndrome. Pediatr Nephrol. 2002;17:413\u20137.","journal-title":"Pediatr Nephrol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-012-0028-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-012-0028-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-012-0028-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T12:44:56Z","timestamp":1559479496000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-012-0028-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,9]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["28"],"URL":"https:\/\/doi.org\/10.1007\/s13730-012-0028-z","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,9]]}}}